Zydus Lifesciences Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 3,646.60 | 2,995.90 | 4,236 |
| Operating Expense | 2,427.70 | 2,285.20 | 1,858.60 |
| Net Profit | 714.50 | 339.60 | 1,722 |
| Net Profit Margin | 19.59% | 11.34% | 40.65% |
| Earning Per Share | 7.15 | 3.38 | 17.11 |
| EBIDTA | 1,220.50 | 712.30 | 2,435.10 |
| Effective Tax Rate | 20.44% | 16.56% | 18.79% |
Particulars
Sep 2026
Revenue3,646.60
Operating Expense2,427.70
Net Profit714.50
Net Profit Margin19.59
Earning Per Share7.15
EBIDTA1,220.50
Effective Tax Rate20.44
